University of Northern Norway Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT00491920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Medical Dpt, University Hospital of Northern Norway

Active Ingredients

Drugs in Phase 4 Trials (1)

vitamin d3 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Diseases, Metabolic (Phase 4)

Insulin Resistance (Phase 2)

Osteoporosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1